# Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach Cancer

> **NCT00477880** · PHASE1 · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 9 (actual)

## Conditions studied

- Gastric Cancer
- Precancerous Condition

## Interventions

- **BIOLOGICAL:** Cetuximab

## Key facts

- **NCT ID:** NCT00477880
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2017-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00477880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00477880, "Cetuximab in Treating Patients With Ménétrier Disease at High Risk of Developing Stomach Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00477880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*